REED THOMAS H 4
4 · NEOGEN CORP · Filed Jan 27, 2020
Insider Transaction Report
Form 4
NEOGEN CORPNEOG
REED THOMAS H
Director
Transactions
- Sale
Common Stock
2020-01-24$69.76/sh−1,000$69,760→ 8,010 total - Exercise/Conversion
Common Stock
2020-01-08$41.35/sh+4,000$165,420→ 12,010 total - Sale
Common Stock
2020-01-08$65.04/sh−6,667$433,647→ 8,010 total - Exercise/Conversion
Common Stock (Right to Buy)
2020-01-08−2,667→ 7,333 totalExercise: $59.13Exp: 2022-10-05→ Common Stock (2,667 underlying) - Exercise/Conversion
Common Stock
2020-01-24$67.72/sh+1,000$67,720→ 9,010 total - Exercise/Conversion
Common Stock (Right to Buy)
2020-01-24−1,000→ 6,333 totalExercise: $67.72Exp: 2023-10-04→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2020-01-08$59.13/sh+2,667$157,700→ 14,677 total - Exercise/Conversion
Common Stock (Right to Buy)
2020-01-08−4,000→ 10,000 totalExercise: $41.35From: 2019-10-06Exp: 2026-10-06→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]Options were granted 10/5/2017, have five year lives, and vest in three equal annual installments of 33% on each of the first three anniversary dates of the grant
- [F2]Options were granted 10/4/2018, have five year lives, and vest in three equal annual installments of 33%, on each of the first three anniversary dates of the grant